A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder

NCT01034995 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

580

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depression

Interventions

DRUG: SSR125543
DRUG: escitalopram
DRUG: placebo

Sponsor

Sanofi